Aevi Genomic Medicine (GNMX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2014 | 06-2014 | 03-2014 | 12-2013 | 09-2013 | |
| Operating Expenses | 3,870 | 3,637 | 5,235 | 5,894 | 4,904 |
| Operating Income | -3,870 | -3,637 | -5,235 | -5,894 | -4,904 |
| Other Income | 832 | -202 | -117 | 698 | -1,239 |
| Pre-tax Income | -3,038 | -3,839 | -5,352 | -5,196 | -6,143 |
| Income Tax | 2 | 1 | 5 | 12 | 0 |
| Net Income Continuous | -3,040 | -3,840 | -5,357 | -5,208 | -6,143 |
| Net Income | $-3,040 | $-3,840 | $-5,357 | $-5,208 | $-6,143 |
| EPS Basic Total Ops | -0.16 | -0.21 | -0.28 | -0.29 | -0.33 |
| EPS Basic Continuous Ops | -0.16 | -0.21 | -0.28 | -0.28 | -0.33 |
| EPS Diluted Total Ops | -0.21 | -0.21 | -0.28 | -0.33 | -0.33 |
| EPS Diluted Continuous Ops | -0.16 | -0.21 | -0.28 | -0.29 | -0.33 |
| EBITDA(a) | $-3,806 | $-3,583 | $-5,191 | $-5,847 | $-4,858 |